41 studies found for:    " April 16, 2008":" May 16, 2008"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
Rank Status Study
1 Unknown  Follow-up on the HIGH: Low Study - the Longterm Effects of Growth Hormone
Conditions: HIV Infections;   HIV-Associated Lipodystrophy Syndrome
Intervention:
2 Completed A Phase I Study of Modified Vaccinia Virus Ankara (MVA-B) in Healthy Volunteers at Low Risk of HIV Infection
Condition: HIV Infections
Interventions: Biological: MVA-B;   Biological: Placebo
3 Completed Sex, Aging and Antiretroviral Pharmacokinetics
Condition: HIV Infections
Intervention: Drug: ARV regimen chosen by treating physician
4 Completed Raltegravir as Early Therapy in African-Americans Living With HIV Study
Condition: HIV Infections
Intervention: Drug: Raltegravir + Truvada
5 Completed Trial Comparing Two Strategies of Vaccination Against Hepatitis B in HIV-infected Patients Non Responding to Primary Immunization (B-BOOST)
Conditions: Hepatitis B;   HIV Infection
Intervention: Biological: GenHevac-B
6 Completed Pharmacokinetic Study of Two Generic co-Formulations of Lopinavir/Ritonavir for HIV Infected Children (SURF)
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir
7 Terminated
Has Results
Eltrombopag To Reduce The Need For Platelet Transfusion In Subjects With Chronic Liver Disease And Thrombocytopenia Undergoing Elective Invasive Procedures
Conditions: Non-alcoholic Steatohepatitis;   Chronic Liver Disease;   HCV;   NASH.;   HIV Infection;   Thrombocytopenia;   Hepatitis C Virus;   HBV;   Human Immunodeficiency Virus;   Liver Diseases;   Hepatitis B Virus
Interventions: Drug: Eltrombopag;   Drug: Placebo
8 Active, not recruiting Prospective Observational Epidemiologic Study of Maraviroc's Safety
Condition: Human Immunodeficiency Virus
Interventions: Drug: Maraviroc along with an optimized background antiretroviral drug regimen;   Drug: Optimized background antiretroviral drug regimen without maraviroc
9 Recruiting Innate Immunity in HIV Positive Patients Co-infected With Hepatitis C Virus (HCV) or Hepatitis B Virus (HBV)
Conditions: HIV-hepatitis Co-infection;   HIV Infections
Intervention:
10 Completed Phase II Study of AGS‑004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
Condition: HIV Infections
Intervention: Biological: AGS-004
11 Terminated Kaletra and Viread in Antiretroviral Naïve Patients
Condition: HIV Infections
Intervention: Drug: Lopinavir/ritonavir and tenofovir
12 Suspended Bioequivalence Study of Didanosine in Children Treated for HIV
Condition: HIV Infections
Intervention: Drug: didanosine
13 Completed Preventing HIV/Aids in Drug Abusing Youth
Condition: HIV Infections
Interventions: Behavioral: IBFT /HIV prevention;   Behavioral: IBFT
14 Completed Rapid HIV Testing for Emergency Department Patients
Condition: HIV Infections
Intervention: Behavioral: HIV risk education
15 Completed Study of Viral Load Decay Rates in HIV Infected Participants Starting Treatment With Raltegravir (RAL) and Emtricitabine/Tenofovir Disoproxil Fumarate (TDF)
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: Emtricitabine/tenofovir disoproxil fumarate
16 Unknown  A Surveillance Program for the Detection of Hepatitis B Virus (HBV) Resistance to Tenofovir in HIV-HBV co-Infected Patients
Conditions: HIV Infections;   Hepatitis B Virus
Intervention:
17 Completed HIV Vertical Transmission in Vietnam
Condition: HIV Infections
Intervention:
18 Completed Pilot Trial of a Synbiotic in HIV+ Patients
Condition: HIV Infection
Interventions: Dietary Supplement: Synbiotic 2000;   Dietary Supplement: Placebo
19 Completed
Has Results
Qualitative Assessment of Implementing Routine Rapid HIV Testing
Condition: HIV Infections
Intervention:
20 Completed Qualitative and Quantitative HIV RNA Detection in Saliva Using the Oragene RNA Kit
Condition: HIV Infections
Intervention:

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years